Message from the Editor-in-Chief
Author:
- 9 January 2026
- journal article
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 56 (1) , 1-4
Abstract
No abstract availableThis publication has 64 references indexed in Scilit:
- The entities enabling scientific fraud at scale are large, resilient, and growing rapidlyProceedings of the National Academy of Sciences, 2025
- Dose selection of novel anticancer drugs: exposing the gap between selected and required dosesThe Lancet Oncology, 2024
- Multi-institutional study of osimertinib dose-optimization in non-small cell lung cancer patients with EGFR activating mutation aged 70 years or older (‘MONEY’ trial)Japanese Journal of Clinical Oncology, 2024
- Cost-effectiveness of surveillance intervals after curative resection of colorectal cancerJapanese Journal of Clinical Oncology, 2024
- Message from the Editor-in-ChiefJapanese Journal of Clinical Oncology, 2024
- Protocol digest of a randomized controlled adaptive Phase II/III trial of neoadjuvant chemotherapy for Japanese patients with oesophagogastric junction adenocarcinoma: Japan Clinical Oncology Group Study JCOG2203 (NEO-JPEG)Japanese Journal of Clinical Oncology, 2023
- Protocol digest of a randomized controlled Phase III study comparing surgery alone versus adjuvant nivolumab versus adjuvant S-1 for locally advanced oesophageal squamous cell carcinoma with no pathological complete response after neoadjuvant chemotherapy followed by curative esophagectomy: Japan Clinical Oncology Group study JCOG2206 (SUNRISE Trial)Japanese Journal of Clinical Oncology, 2023
- End-of-life walking ability in cancer patients with spinal metastasesJapanese Journal of Clinical Oncology, 2023
- A phase III randomized controlled trial comparing local field with additional prophylactic irradiation in chemoradiotherapy for clinical-T1bN0M0 esophageal cancer: ARMADILLO trial (JCOG1904)Japanese Journal of Clinical Oncology, 2023
- Message from the Editor-in-ChiefJapanese Journal of Clinical Oncology, 2022